Document Detail

Correlation between cortisol levels and myocardial infarction mortality among intensive coronary care unit patients during first seven days in hospital.
MedLine Citation:
PMID:  15931696     Owner:  NLM     Status:  MEDLINE    
AIM: To measure cortisol level, its relationship with myocardial infarction, and to determine the correlation of elevated cortisol levels with the outcome of myocardial infarction. METHODS: This study was designed as a pre and post study. The diagnosis of myocardial infarction was established based on the WHO criteria. The patients were followed for seven days. Blood specimens were collected on day 1, 3, 5 and 7. RESULTS: Thirty six patients with myocardial infarction were studied. Four patients (11.1%) died and 32 patients (88.9%) survived. Nineteen patients (52.7%) had large infarcts and 23 patients (63.9%) had myocardial complications. The deceased patient's cortisol level differed significantly from those tht survived (65.68 + 29.07 vs 21350 + 15.82 microg/dl, p < 0.05). The groups with large infarcts and myocardial infarct complications had higher cortisol levels, but the difference was not significant compared with the group with small infarcts and patients without complications. Six patients (16.6%) who received thrombolytic therapy had significantly lower cortisol levels as compared to patients without thrombolytic therapy. The duration of elevation cortisol elevation in the deceased patient was longer than that among those who survived. Similar findings were also true for those with large infarcts when compared to those with small infarcts, as well as myocardial infarct patients with complications when compared to those without. However, the duration of cortisol elevation was shorter among patients who received thrombolytic therapy. CONCLUSION: Cortisol level can be used as a prognostic marker for myocardial mortality.
Imran Nito; Sarwono Waspadji; S Harun; H M S Markum
Related Documents :
8942226 - Causes of death from myocardial infarction before and after thrombolysis era: a patholo...
8990406 - Patency trials with reteplase (r-pa): what do they tell us?
9594336 - Evaluation of the patency rate of infarct-related artery after intravenous urokinase in...
1777916 - Prognosis following interventional therapy for acute myocardial infarction: utility of ...
21897916 - Clinical characteristics of patients with atrial fibrillation at a tertiary care hospit...
16100486 - Difference in filtered-back projection and iterative reconstruction in a patient with i...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Acta medica Indonesiana     Volume:  36     ISSN:  0125-9326     ISO Abbreviation:  Acta Med Indones     Publication Date:    2004 Jan-Mar
Date Detail:
Created Date:  2005-06-02     Completed Date:  2005-09-01     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7901042     Medline TA:  Acta Med Indones     Country:  Indonesia    
Other Details:
Languages:  eng     Pagination:  8-14     Citation Subset:  IM    
Division of Renal-Hypertension, Department of Internal Medicine, Faculty of Medicine, University of Indonesia, Jakarta.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Acute Disease
Biological Markers / blood
Coronary Care Units*
Hospital Mortality
Hydrocortisone / blood*
Middle Aged
Myocardial Infarction / blood*,  complications,  drug therapy,  mortality*
Survival Analysis
Thrombolytic Therapy
Time Factors
Reg. No./Substance:
0/Biological Markers; 50-23-7/Hydrocortisone
Comment In:
Acta Med Indones. 2004 Jan-Mar;36(1):1-2   [PMID:  15931694 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Comparison of The World Health Organization (WHO) two-step strategy and OGTT for diabetes mellitus s...
Next Document:  Relationship between creatinine clearance and plasma homocysteine levels in predialytic chronic rena...